KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Capital Expenditures (2016 - 2025)

CareDx's Capital Expenditures history spans 13 years, with the latest figure at -$733000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 83.07% year-over-year to -$733000.0; the TTM value through Dec 2025 reached $3.2 million, up 406.95%, while the annual FY2025 figure was $3.2 million, 406.95% up from the prior year.
  • Capital Expenditures for Q4 2025 was -$733000.0 at CareDx, down from $1.3 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $8.5 million in Q1 2022 and bottomed at -$6.1 million in Q4 2023.
  • The 5-year median for Capital Expenditures is $1.7 million (2024), against an average of $1.5 million.
  • The largest annual shift saw Capital Expenditures tumbled 954.09% in 2021 before it skyrocketed 577.04% in 2022.
  • A 5-year view of Capital Expenditures shows it stood at -$3.8 million in 2021, then surged by 187.2% to $3.3 million in 2022, then tumbled by 286.24% to -$6.1 million in 2023, then rose by 29.07% to -$4.3 million in 2024, then skyrocketed by 83.07% to -$733000.0 in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Capital Expenditures are -$733000.0 (Q4 2025), $1.3 million (Q3 2025), and $1.0 million (Q2 2025).